Brightline Ventures Backs Heat Biologics
Heat Biologics, a Miami, Fla.-based off-the-shelf drug developer, has raised an undisclosed amount of first-round funding led by Brightline Ventures. The company's initial focus is on therapeutic vaccines to treat non small cell lung cancer.
27 May 2010•3 mins read
